Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain

被引:25
作者
Hara, K
Kudoh, H
Enomoto, T
Hashimoto, Y
Masuko, T
机构
[1] Kinki Univ, Sch Pharmaceut Sci, Cell Biol Lab, Higashiosaka, Osaka 5778502, Japan
[2] Tohoku Univ, Grad Sch Pharmaceut Sci, Mol Cell Biol Lab, Aoba Ku, Sendai, Miyagi 9808578, Japan
[3] Sasaki Inst, Chikusa Ku, Tokyo 101, Japan
关键词
CD98; transfectant; extracellular domain;
D O I
10.1038/sj.onc.1204019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
GP125/CD98 is a heterodimeric 125-kDa glycoprotein, which consists of an 85-kDa heavy chain the) and a 40-kDa light chain (Ic), and is strongly expressed on the cell surface of various tumor cells, irrespective of their tissue of origin. We have recently demonstrated that over-expression of the CD98hc cDNA causes malignant transformation of NIH3T3 cells. To investigate the function of the extracellular domain of CD98hc in cell proliferation and malignant transformation, we established two NIH3T3-derived clones transfected with human truncated CD98hc cDNAs, and compared their characteristics with parental NIH3T3 and clones transfected with full-length CD98hc cDNA, Truncated as well as full-length CD98hc-transfected clones grew to a higher saturation density than control cells. Efficiency of colony formation in soft agar was augmented in all CD98hc-transfected clones, and the degrees of augmented colony formation of the transfectants expressing full-length CD98hc of 529 a.a. or truncated CD98hc of 418 a,a, were reduced by anti-human CD98hc antibodies, while that of the transfectant expressing truncated CD98hc of 237 a,a, lacking the epitopes recognized by anti-human CD98hc antibodies was not affected by the addition of antibodies. CD98hc-transfected clones developed tumors in athymic mice, and tumor growth of truncated CD98hc-transfected clones was faster than that of full-length CD98hc-transfected clones.
引用
收藏
页码:6209 / 6215
页数:7
相关论文
共 57 条
[1]   STIMULATION OF SYSTEM Y+-LIKE AMINO-ACID-TRANSPORT BY THE HEAVY-CHAIN OF HUMAN 4F2 SURFACE-ANTIGEN IN XENOPUS-LAEVIS OOCYTES [J].
BERTRAN, J ;
MAGAGNIN, S ;
WERNER, A ;
MARKOVICH, D ;
BIBER, J ;
TESTAR, X ;
ZORZANO, A ;
KUHN, LC ;
PALACIN, M ;
MURER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5606-5610
[2]  
Bouck N, 1979, Methods Enzymol, V58, P296
[3]   The 4F2hc surface antigen is necessary for expression of system L-like neutral amino acid-transport activity in C6-BU-1 rat glioma cells: Evidence from expression studies in Xenopus laevis oocytes [J].
Broer, S ;
Broer, A ;
Hamprecht, B .
BIOCHEMICAL JOURNAL, 1995, 312 :863-870
[4]   TRANSFORMING ACTIVITY OF DNA OF CHEMICALLY TRANSFORMED AND NORMAL-CELLS [J].
COOPER, GM ;
OKENQUIST, S ;
SILVERMAN, L .
NATURE, 1980, 284 (5755) :418-421
[5]   ISOLATION AND CHARACTERIZATION OF A HETERODIMERIC SURFACE-ANTIGEN ON HUMAN-MELANOMA CELLS AND EVIDENCE THAT IT IS THE 4F2 CELL ACTIVATION PROLIFERATION MOLECULE [J].
DIXON, WT ;
SIKORA, LKJ ;
DEMETRICK, DJ ;
JERRY, LM .
INTERNATIONAL JOURNAL OF CANCER, 1990, 45 (01) :59-68
[6]   Galectin-3 stimulates uptake of extracellular Ca2+ in human Jurkat T-cells [J].
Dong, S ;
Hughes, RC .
FEBS LETTERS, 1996, 395 (2-3) :165-169
[7]   CLOSE SIMILARITY OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND V-ERB-B ONCOGENE PROTEIN SEQUENCES [J].
DOWNWARD, J ;
YARDEN, Y ;
MAYES, E ;
SCRACE, G ;
TOTTY, N ;
STOCKWELL, P ;
ULLRICH, A ;
SCHLESSINGER, J ;
WATERFIELD, MD .
NATURE, 1984, 307 (5951) :521-527
[8]   Complementation of dominant suppression implicates CD98 in integrin activation [J].
Fenczik, CA ;
Sethi, T ;
Ramos, JW ;
Hughes, PE ;
Ginsberg, MH .
NATURE, 1997, 390 (6655) :81-85
[9]   Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98 [J].
Hara, K ;
Kudoh, H ;
Enomoto, T ;
Hashimoto, Y ;
Masuko, T .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 262 (03) :720-725
[10]  
Hashimoto Y, 1983, Gan, V74, P819